Log in
Enquire now
‌

US Patent 11911473 Compositions and kits for omeprazole suspension

Patent 11911473 was granted and assigned to Azurity Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Azurity Pharmaceuticals
Azurity Pharmaceuticals
0
Date Filed
March 30, 2023
0
Date of Patent
February 27, 2024
0
Patent Applicant
Azurity Pharmaceuticals
Azurity Pharmaceuticals
0
Patent Application Number
18128344
0
Patent Citations
‌
US Patent 11207307 Composition and method for proton pump inhibitor suspension
0
‌
US Patent 7300670 Oral suspension formulation
0
‌
US Patent 7815933 Self emulsifying drug delivery system
0
‌
US Patent 10751333 Compositions and kits for omeprazole suspension
0
‌
US Patent 11103492 Compositions and kits for omeprazole suspension
0
‌
US Patent 11633478 Compositions and kits for Omeprazole suspension
0
Patent Inventor Names
Zeus Pendon
0
Steven Dinh
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11911473
0
Patent Primary Examiner
‌
Timothy P Thomas
0
CPC Code
‌
A61K 9/0095
0
‌
A61P 1/04
0
‌
A61K 47/02
0
‌
A61K 47/10
0
‌
A61K 47/38
0
‌
A61K 47/24
0

Find more entities like US Patent 11911473 Compositions and kits for omeprazole suspension

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.